Healthcare provider profile · identity verified

Greg Alan Grisso, MD

Internal Medicine · ASHEBORO, NC · NPI 1194883538

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	540	155
Losartan Potassium	Losartan Potassium	540	151
Levothyroxine Sodium	Levothyroxine Sodium	496	127
Rosuvastatin Calcium	Rosuvastatin Calcium	466	138
Omeprazole	Omeprazole	455	135
Amlodipine Besylate	Amlodipine Besylate	405	128
Pantoprazole Sodium	Pantoprazole Sodium	324	100
Hydrochlorothiazide	Hydrochlorothiazide	290	82
Metoprolol Succinate	Metoprolol Succinate	289	74
Alprazolam	Alprazolam	276	57
Lisinopril	Lisinopril	257	76
Metformin Hcl Er	Metformin Hcl	243	70
Furosemide	Furosemide	235	73
Eliquis	Apixaban	227	43
Sertraline Hcl	Sertraline Hcl	185	63
Tamsulosin Hcl	Tamsulosin Hcl	182	51
Glimepiride	Glimepiride	177	50
Carvedilol	Carvedilol	170	49
Gabapentin	Gabapentin	165	52
Escitalopram Oxalate	Escitalopram Oxalate	162	45
Simvastatin	Simvastatin	155	41
Pravastatin Sodium	Pravastatin Sodium	140	37
Clopidogrel	Clopidogrel Bisulfate	134	36
Allopurinol	Allopurinol	132	39
Potassium Chloride	Potassium Chloride	128	39
Alendronate Sodium	Alendronate Sodium	127	38
Metoprolol Tartrate	Metoprolol Tartrate	123	35
Januvia	Sitagliptin Phosphate	118	25
Albuterol Sulfate Hfa	Albuterol Sulfate	115	43
Prednisone	Prednisone	109	81
Fluticasone Propionate	Fluticasone Propionate	104	38
Montelukast Sodium	Montelukast Sodium	98	30
Tramadol Hcl	Tramadol Hcl	92	21
Metformin Hcl	Metformin Hcl	90	28
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	89	26
Zolpidem Tartrate	Zolpidem Tartrate	87	24
Donepezil Hcl	Donepezil Hcl	85	30
Duloxetine Hcl	Duloxetine Hcl	81	23
Finasteride	Finasteride	81	26
Spironolactone	Spironolactone	81	25
Atenolol	Atenolol	78	20
Jardiance	Empagliflozin	76	18
Citalopram Hbr	Citalopram Hydrobromide	73	20
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	70	15
Celecoxib	Celecoxib	68	25
Ezetimibe	Ezetimibe	56	15
Glipizide Er	Glipizide	55	15
Trazodone Hcl	Trazodone Hcl	54	16
Doxycycline Hyclate	Doxycycline Hyclate	53	39
Valsartan	Valsartan	53	12
Quetiapine Fumarate	Quetiapine Fumarate	50	13
Synthroid	Levothyroxine Sodium	50	12
Fenofibrate	Fenofibrate	48	15
Meloxicam	Meloxicam	48	16
Oxybutynin Chloride Er	Oxybutynin Chloride	47	15
Lorazepam	Lorazepam	46	13
Famotidine	Famotidine	45	16
Bupropion Xl	Bupropion Hcl	44	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	44	suppressed
Mounjaro	Tirzepatide	44	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	43	39
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	41	16
Clonazepam	Clonazepam	39	18
Olmesartan Medoxomil	Olmesartan Medoxomil	39	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	37	35
Esomeprazole Magnesium	Esomeprazole Magnesium	36	15
Estradiol	Estradiol	36	suppressed
Azithromycin	Azithromycin	35	32
Hydralazine Hcl	Hydralazine Hcl	35	12
Tradjenta	Linagliptin	33	suppressed
Benazepril Hcl	Benazepril Hcl	31	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	31	suppressed
Pregabalin	Pregabalin	31	suppressed
Lovastatin	Lovastatin	26	suppressed
Memantine Hcl	Memantine Hcl	26	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	26	suppressed
Xarelto	Rivaroxaban	26	suppressed
Bupropion Hcl	Bupropion Hcl	25	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	25	24
Paroxetine Hcl	Paroxetine Hcl	25	suppressed
Levetiracetam	Levetiracetam	24	suppressed
Ropinirole Hcl	Ropinirole Hcl	24	suppressed
Breo Ellipta	Fluticasone/Vilanterol	23	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	23	suppressed
Telmisartan	Telmisartan	23	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	22	suppressed
Bupropion Hcl Sr	Bupropion Hcl	21	suppressed
Linzess	Linaclotide	21	suppressed
Temazepam	Temazepam	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Enalapril Maleate	Enalapril Maleate	20	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	19	suppressed
Buspirone Hcl	Buspirone Hcl	19	suppressed
Diazepam	Diazepam	19	suppressed
Ozempic	Semaglutide	19	suppressed
Irbesartan	Irbesartan	18	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	18	suppressed
Nystatin	Nystatin	18	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	18	suppressed
Primidone	Primidone	18	suppressed
Risperidone	Risperidone	18	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	17	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	17	suppressed
Warfarin Sodium	Warfarin Sodium	17	suppressed
Ramipril	Ramipril	16	suppressed
Torsemide	Torsemide	16	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	15	suppressed
Latanoprost	Latanoprost	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Onglyza	Saxagliptin Hcl	15	suppressed
Dilt-Xr	Diltiazem Hcl	14	suppressed
Humalog Kwikpen U-100	Insulin Lispro	14	suppressed
Nabumetone	Nabumetone	14	suppressed
Ventolin Hfa	Albuterol Sulfate	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Testosterone Cypionate	Testosterone Cypionate	12	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	12	suppressed
Trulicity	Dulaglutide	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Colchicine	Colchicine	11	suppressed
Digoxin	Digoxin	11	suppressed
Klor-Con M10	Potassium Chloride	11	suppressed
Methimazole	Methimazole	11	suppressed
Mometasone Furoate	Mometasone Furoate	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error